drugset / Trial / NCT04486430

Efficacy and Safety Study of Neu2000KWL for Acute Ischemic Stroke Patients Within 6 Hours of Onset

NCT04486430 ↗

Phase 2 Completed 236 enrolled Beijing Tiantan Hospital Daqing Oil Field Hospital · collabFirst Affiliated Hospital of Jinan University · collabFirst Affiliated Hospital of Wenzhou Medical University · collabFirst Affiliated Hospital of Zhejiang University · collabFirst Hospital of China Medical University · collabGeneral Hospital of Shenyang Military Region · collabGuangzhou First People's Hospital · collabHebei General Hospital · collabHebei Medical University Third Hospital · collabInner Mongolia Baogang Hospital · collabNanfang Hospital, Southern Medical University · collabNanjing PLA General Hospital · collabPeking University First Hospital · collabPeking University Third Hospital · collabQilu Hospital of Shandong University · collabSecond Affiliated Hospital of Guangzhou Medical University · collabSecond Affiliated Hospital, School of Medicine, Zhejiang University · collabSecond Hospital of Shanxi Medical University · collabShandong Provincial Hospital · collabShanghai General Hospital, Shanghai Jiao Tong University School of Medicine · collabShanghai Minhang Central Hospital · collabShanghai Pudong New Area People's Hospital · collabSubei People's Hospital of Jiangsu Province · collabSun Yat-Sen Memorial Hospital of Sun Yat-Sen University · collabThe Central Hospital of Lishui City · collabThe First Affiliated Hospital of BaoTou Medical College · collabThe First Affiliated Hospital of Soochow University · collabThe First Hospital of Jilin University · collabThe Second Hospital of Hebei Medical University · collabTianjin First Central Hospital · collabTianjin Huanhu Hospital · collabTongji Hospital · collabXiangya Hospital of Central South University · collabXuanwu Hospital, Beijing · collabZhejiang Apeloa Jiayuan Pharmaceutical Co. Ltd. · collab
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of the study is to explore safety and efficacy of Salfaprodil administration for patients with acute ischemic stroke within 6 hours of onset.

Timeline

Start
2017-03-02
Primary completion
2019-06-12
Completion
2019-12-13

Drugs

EvaluationDrugModalityDoseRoute
Subject Neu2000KWL Unknown 250 mg Intravenous
Subject Neu2000KWL Unknown 500 mg Intravenous

Indications